Elixinol Wellness Limited ELLXF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.31M | -2.94M | -3.54M | -2.41M | -1.28M |
| Total Depreciation and Amortization | 491.70K | 526.60K | 558.60K | 605.60K | 657.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -361.50K | 27.70K | 408.90K | 657.80K | 908.10K |
| Change in Net Operating Assets | 494.10K | 494.10K | 494.10K | -759.10K | -2.04M |
| Cash from Operations | -1.69M | -1.89M | -2.08M | -1.91M | -1.75M |
| Capital Expenditure | -48.50K | -45.50K | -42.40K | -30.20K | -18.20K |
| Sale of Property, Plant, and Equipment | 32.30K | 16.10K | -- | -- | -- |
| Cash Acquisitions | -76.70K | -76.70K | -76.70K | -191.80K | -311.30K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.20K | -21.10K | -21.90K | -16.30K | -10.70K |
| Cash from Investing | -112.80K | -126.90K | -140.80K | -238.10K | -340.10K |
| Total Debt Issued | 605.00K | 1.11M | 1.61M | 1.93M | 2.26M |
| Total Debt Repaid | -301.00K | -303.00K | -305.00K | -634.50K | -964.00K |
| Issuance of Common Stock | 2.54M | 2.61M | 2.69M | 2.17M | 1.65M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -327.00K | -333.00K | -339.00K | -260.00K | -181.00K |
| Cash from Financing | 1.66M | 2.01M | 2.36M | 2.07M | 1.78M |
| Foreign Exchange rate Adjustments | 71.60K | 71.00K | 70.50K | 26.80K | -16.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -72.80K | 71.00K | 214.10K | -52.90K | -324.10K |